Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| HM20000410 | Other Identifier | Office of Research Subject Protection |
Not provided
Not provided
Not provided
study closed due to slow accrual
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients in the intervention arm will view the 23-minute video depicting the Hematopoietic stem cell transplantation (HSCT) experience. Patients in the control arm will receive HSCT frequently asked questions (FAQ) sheet developed by the National Cancer Institute (NCI) at the National Institutes of Health (NIH).
The study's overall goals are 1) to improve outcomes; and 2) to increase satisfaction with the physician consultation.
Patients will be randomized to intervention or control and data will be collected at three time points (before treatment, 30 days post-HSCT and 12 months post-HSCT).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Video | Experimental | Patients will view the 23-minute "Guide to Stem Cell Transplantation" video depicting the HSCT experience |
|
| FAQ Sheet | Active Comparator | Patients will receive HSCT FAQ sheet developed by the NCI at the NIH |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Video | Behavioral | 23-minute video |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in emergency department visits | Data will be collected through review of medical and insurance billing records | Up to 12 months after HSCT |
| Change in number of hospitalizations | Data will be collected through review of medical and insurance billing records | Up to 12 months after HSCT |
| Measure | Description | Time Frame |
|---|---|---|
| Perception of satisfaction with the physician consultation | The Physician consultation will be measured by the Patient Satisfaction Communication Questionnaire (PSCQA). Participants are asked to rate their experience with the physician consultation. There are 17 items, 8 positively worded and 9 negatively worded. Each item is rated on a 5 point likert scale with 1 being strongly agree to 5 being strongly disagree. The maximum score on the PSCQ is 85. The measure takes approximately 4 minutes to administer. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Robin K Matsuyama, PhD | Virginia Commonwealth University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Virginia Commonwealth University | Richmond | Virginia | 23298 | United States |
Not provided
| ID | Term |
|---|---|
| D007938 | Leukemia |
| D009369 | Neoplasms |
| D009101 | Multiple Myeloma |
| ID | Term |
|---|---|
| D009370 | Neoplasms by Histologic Type |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D054219 | Neoplasms, Plasma Cell |
Not provided
Not provided
| ID | Term |
|---|---|
| D014743 | Videotape Recording |
| ID | Term |
|---|---|
| D013637 | Tape Recording |
| D001296 | Audiovisual Aids |
| D018961 | Educational Technology |
| D013672 | Technology |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| FAQ Sheet | Behavioral |
|
|
| Up to 12 months after HSCT |
| D020141 | Hemostatic Disorders |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D010265 | Paraproteinemias |
| D001796 | Blood Protein Disorders |
| D006474 | Hemorrhagic Disorders |
| D008232 | Lymphoproliferative Disorders |
| D007160 | Immunoproliferative Disorders |
| D007154 | Immune System Diseases |
| D013676 |
| Technology, Industry, and Agriculture |
| D013690 | Television |